CIBC Says Rate Cut Means Time Has Come to Buy Discount Bank Stocks

Now is the time for equity investors to move out of premium-traded Canadian banks and into discounted banks, analysts at Canadian Imperial Bank of Commerce said, citing lower interest rates and easing of economic risks that give the cheaper stocks more earnings upside.

Bloomberg
Published21 Sep 2024, 12:42 AM IST
CIBC Says Rate Cut Means Time Has Come to Buy Discount Bank Stocks
CIBC Says Rate Cut Means Time Has Come to Buy Discount Bank Stocks

(Bloomberg) -- Now is the time for equity investors to move out of premium-traded Canadian banks and into discounted banks, analysts at Canadian Imperial Bank of Commerce said, citing lower interest rates and easing of economic risks that give the cheaper stocks more earnings upside.

CIBC said it upgraded Bank of Nova Scotia to an outperformer rating and demoted National Bank of Canada to neutral as borrowing costs ease and fading economic risks mean banks don’t have to set as much money aside for bad loans. That gives Scotiabank an opportunity to catch up to National Bank, with analyst Paul Holden saying valuation spreads are still wide.

“We think these conditions set the stage for a trade out of the premium banks into the discounted banks,” Holden wrote in a Thursday note.

Holden said the switch trade would work particularly well if expectations for provisions for credit losses — the amount banks set aside for loans potentially going sour — start to come down since discounted banks tend to post the highest ratios.

CIBC said it chose Scotiabank as the “right trade,” because it could post the highest earnings growth rate over the next two fiscal years given its unique exposure that could see net interest margin improvements from rate cuts and a tailwind from declining loan loss provisions. The CIBC analysts updated their earnings estimates for Scotiabank in the next fiscal year to be 2% higher, and 5% higher in fiscal 2026.

The team also noted that Toronto-Dominion Bank is trading at a 7% discount to the group. They expect that gap to narrow once anti-money laundering issues in the US are settled by the end of the year.

“TD has been posting solid fundamental results, and we think concerns over future earnings growth have been exaggerated,” Holden wrote. “We also believe the CEO succession signals a global AML settlement is close.”

National Bank has outperformed all of its peers except for CIBC, which soared in late August after it said its US office portfolio problems have eased. National Bank has gained nearly 26% year-to-date, compared to 13% in the S&P/TSX Composite index banking subgroup. 

On Friday, Scotiabank shares rose as much as 1.5% in early trading. National Bank, on the other hand, slid by the same amount.  

What Bloomberg Intelligence Says

“Scotiabank is counting on its strategic shift to North America from the Pacific Alliance to bring its profitability and risk measures closer to peers. It trails its better-than-14% midterm ROE goal, which is marginally below competitors. International exposure keeps credit-reserve ratios above rivals, while the bank is targeting improved efficiency, along with other large Canadian banks” - Paul Gulberg, BI Senior Industry Analyst

More stories like this are available on bloomberg.com

©2024 Bloomberg L.P.

Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:21 Sep 2024, 12:42 AM IST
Business NewsCompaniesNewsCIBC Says Rate Cut Means Time Has Come to Buy Discount Bank Stocks

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Vedanta share price

    472.05
    03:59 PM | 17 OCT 2024
    -14.75 (-3.03%)

    Tata Steel share price

    152.35
    03:58 PM | 17 OCT 2024
    -2.9 (-1.87%)

    Bharat Petroleum Corporation share price

    342.50
    03:55 PM | 17 OCT 2024
    -8.35 (-2.38%)

    Tata Power share price

    450.05
    03:41 PM | 17 OCT 2024
    -10.3 (-2.24%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Coforge share price

    7,120.75
    10:51 AM | 7 OCT 2024
    -2.4 (-0.03%)

    Vijaya Diagnostic Centre share price

    984.80
    10:51 AM | 7 OCT 2024
    -4.15 (-0.42%)

    Dr. Lal Pathlabs share price

    3,408.00
    10:50 AM | 7 OCT 2024
    -86.25 (-2.47%)
    More from 52 Week High

    Bombay Burmah Trading Corporation share price

    2,519.95
    10:51 AM | 7 OCT 2024
    -245.3 (-8.87%)

    Jubilant Ingrevia share price

    728.55
    10:51 AM | 7 OCT 2024
    -65.7 (-8.27%)

    Triveni Engineering & Indus share price

    426.65
    10:51 AM | 7 OCT 2024
    -35.75 (-7.73%)

    Vodafone Idea share price

    9.08
    10:51 AM | 7 OCT 2024
    -0.72 (-7.35%)
    More from Top Losers

    Astrazeneca Pharma India share price

    7,832.35
    10:51 AM | 7 OCT 2024
    399.85 (5.38%)

    Finolex Industries share price

    280.85
    10:51 AM | 7 OCT 2024
    9.2 (3.39%)

    Macrotech Developers share price

    1,206.20
    10:51 AM | 7 OCT 2024
    34.35 (2.93%)

    JK Lakshmi Cement share price

    797.60
    10:51 AM | 7 OCT 2024
    17.2 (2.2%)
    More from Top Gainers

      Recommended For You

        More Recommendations

        Gold Prices

        • 24K
        • 22K

        Fuel Price

        • Petrol
        • Diesel
        Bangalore
        102.86/L0.00
        Chennai
        100.85/L0.00
        Kolkata
        104.95/L0.00
        New Delhi
        94.72/L0.00

        Popular in Companies

          HomeMarketsloanPremiumMint Shorts